Results 101 to 110 of about 64,013 (258)
ABSTRACT Prenatal exome sequencing (ES) can establish rare genetic diagnoses in a fetus but may also lead to occult genetic diagnosis in a biological parent. We present a case of dual fetal and maternal diagnosis by prenatal ES, in a fetus with unexplained anemia and in a pregnant patient with sickle cell disease (SCD) and recurrent unexplained hypoxia.
Matthew A. Shear +6 more
wiley +1 more source
Post-transfusion reactions: update for the best professional and technical performance
Introduction: numerous, varied and dangerous transfusion reactions make it necessary to recognize its clinic and treatment to identify them early and prevent their consequences. Objective: to evaluate the updated information published in the national
María Adelaida González Bazart +4 more
doaj
Hemophilia A: An Ideal Disease for Prenatal Therapy
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada +2 more
wiley +1 more source
Pilot study on the use of basophil activation tests and skin tests for the prevention of allergic transfusion reactions. [PDF]
Akiki P +12 more
europepmc +1 more source
The Kaohsiung Journal of Medical Sciences, EarlyView.
Wan‐Hua Yang, Fen‐Cing Liou
wiley +1 more source
Diagnosis and Management of Prenatal Hereditary Pyropoikilocytosis
ABSTRACT Hereditary pyropoikilocytosis (HPP) is a severe hemolytic anemia caused by variants in SPTA1, SPTB, and EPB41. These weaken horizontal interactions in the erythrocyte cytoskeleton, causing membrane fragmentation and splenic sequestration. It will readily cause fetal anemia and often hydrops fetalis. Prenatal diagnosis requires first ruling out
Connor Hartzell +6 more
wiley +1 more source
IMMUNOHEMATOLOGICAL EVALUATION OF TRANSFUSION REACTIONS
Background. The decision, made by transfusion medicine specialist, for the extent of investigation of the transfusion reaction is based on the clinical course of transfusion reaction, reported by the patient´s physician.
Marjeta Maček +4 more
doaj
This preclinical study evaluated a novel controlled‐expansion expanded polytetrafluoroethylene (ePTFE)‐covered transjugular intrahepatic portosystemic shunt (TIPS) stent in 11 swine, demonstrating 100% technical success, excellent deployability, and durable 6‐month angiographic patency without thrombosis, migration, fracture, or device‐related toxicity.
Yi Xiang +15 more
wiley +1 more source
Investigation of the patients with recurrent acute transfusion reactions: A single tertiary medical centre experience. [PDF]
Hsieh MY, Chen JS, Yin CH.
europepmc +1 more source
We propose mild‐MHT protocol for the quick internalization of magnetic nanoparticles (MNPs) by immune cells. The heat induced by MNPs under alternating magnetic field stimulate MNPs diffusion and cell membrane invagination, accelerating the cellular internalization of MNPs. ABSTRACT Immune cell therapies show promise in hematologic malignancies and are
Giulia E. P. Nucci +8 more
wiley +1 more source

